The following resources are provided to assist clinicians considering providing doxycycline post-exposure prophylaxis (Doxy PEP) to their patients.

CDC Response to Doxy-PEP data presented at 2022 International AIDS Conference | Newsroom | NCHHSTP | CDC
https://www.cdc.gov/nchhstp/newsroom/2022/Doxy-PEP-clinical-data-presented-at-2022-AIDS-Conference.html

CDC Considerations for Doxy-PEP Use
https://www.cdc.gov/std/treatment-guidelines/clinical-primary.htm#CautionsForDoxyPEP

NEJM. Article: Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Download

Lancet Article: Post-exposure Prophylaxis with Doxycycline to Prevent Sexually Transmitted Infections in Men Who Have Sex with Men: an Open-Label Randomised Substudy of the ANRS IPERGAY Trial
Download

Doxy-PEP Abstracts from CROI 2023 with Links to Presentations
Download

Last Updated August 8, 2023